1. Home
  2. NUVB vs DDL Comparison

NUVB vs DDL Comparison

Compare NUVB & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • DDL
  • Stock Information
  • Founded
  • NUVB 2018
  • DDL 2014
  • Country
  • NUVB United States
  • DDL China
  • Employees
  • NUVB N/A
  • DDL N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • DDL Catalog/Specialty Distribution
  • Sector
  • NUVB Health Care
  • DDL Consumer Discretionary
  • Exchange
  • NUVB Nasdaq
  • DDL Nasdaq
  • Market Cap
  • NUVB 679.9M
  • DDL 666.1M
  • IPO Year
  • NUVB N/A
  • DDL 2021
  • Fundamental
  • Price
  • NUVB $1.77
  • DDL $2.71
  • Analyst Decision
  • NUVB Strong Buy
  • DDL
  • Analyst Count
  • NUVB 6
  • DDL 0
  • Target Price
  • NUVB $8.33
  • DDL N/A
  • AVG Volume (30 Days)
  • NUVB 2.9M
  • DDL 828.3K
  • Earning Date
  • NUVB 03-06-2025
  • DDL 03-06-2025
  • Dividend Yield
  • NUVB N/A
  • DDL N/A
  • EPS Growth
  • NUVB N/A
  • DDL N/A
  • EPS
  • NUVB N/A
  • DDL 0.13
  • Revenue
  • NUVB $7,873,000.00
  • DDL $3,158,412,712.00
  • Revenue This Year
  • NUVB $47.99
  • DDL $17.17
  • Revenue Next Year
  • NUVB $551.81
  • DDL $14.00
  • P/E Ratio
  • NUVB N/A
  • DDL $21.52
  • Revenue Growth
  • NUVB N/A
  • DDL 4.61
  • 52 Week Low
  • NUVB $1.70
  • DDL $1.08
  • 52 Week High
  • NUVB $3.97
  • DDL $4.79
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 34.81
  • DDL 34.70
  • Support Level
  • NUVB $1.85
  • DDL $2.79
  • Resistance Level
  • NUVB $2.04
  • DDL $2.95
  • Average True Range (ATR)
  • NUVB 0.13
  • DDL 0.14
  • MACD
  • NUVB -0.01
  • DDL -0.02
  • Stochastic Oscillator
  • NUVB 9.66
  • DDL 12.61

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: